- Less than half of the patients with ectopic pregnancy present with the classic triad of a history of amenorrhea, abdominal pain, and irregular vaginal bleeding (C).
- Definite cervical motion tenderness and peritoneal signs are the most sensitive and specific examination findings for ectopic pregnancy—91% and 95%, respectively (A).
- Beta-human chorionic gonadotropin (β-hCG) levels can be used in combination with ultrasound findings to improve the accuracy of the diagnosis of ectopic pregnancy (A).
- Women with initial nondiagnostic transvaginal ultrasound should be followed with serial β-hCGs (B).
Despite advanced detection methods, ectopic pregnancy may be missed in 40% to 50% of patients on an initial visit.1 Most women with ectopic pregnancy have no risk factors (TABLE 1),2-5 and the classic triad of a history of amenorrhea, abdominal pain, and irregular vaginal bleeding is absent in more than half of cases.
Early diagnosis not only decreases maternal mortality and morbidity; it also helps preserve future reproductive capacity—only one third of women with ectopic pregnancy have subsequent live births.2
Management strategies for patients with ectopic pregnancy have evolved rapidly, with ambulatory medical therapy becoming an option for more patients.6 Using a practical decision protocol, we discuss the physical findings that most reliably suggest ectopic pregnancy, describe sensible use of laboratory and imaging studies, and explain what to do when results are equivocal. In part 2 of this article (coming in the June 2006 Journal of Family Practice), we provide a decision protocol for management of ectopic pregnancy.
TABLE 1
Risk factors for ectopic pregnancy
DEGREE OF RISK | FACTOR | ODDS RATIO (95% CONFIDENCE INTERVALS) | ||
---|---|---|---|---|
ANKUM ET AL3 | MOL ET AL4 | BOUYER ET AL5 | ||
High | Previous tubal surgery | 21 (9.3–47) | 4.0 (2.6–6.1) | |
Tubal ligation | 9.3 (4.9–18) | |||
Previous ectopic pregnancy | 8.3 (6.0–11.5) | |||
In utero DES exposure | 5.6 (2.4–13) | |||
Current IUD use | 4.2–45* | |||
Tubal pathology/abnormality | 3.5–25* | |||
Moderate | Infertility | 2.5–21* | 2.7 (1.8–4.2) | |
History of PID | 2.5 (2.1–3.0) | 3.4 (2.4–5.0) | ||
Previous chlamydial or gonococcal infection | 2.8–3.7* | |||
Current smoking | 2.3 (2.0–2.8) | 3.9 (2.6–5.9) | ||
Spontaneous abortions ≥3 | 3.0 (1.3–6.9) | |||
Induced abortions (medical±surgical) | 2.8 (1.1–7.2) | |||
Lifetime sexual partners >1 | 2.1 (1.4–4.8) | |||
Low | Age first intercourse <18 years | 1.6 (1.1–2.5) | ||
Previous pelvic/abdominal surgery | 0.93–3.8* | |||
Vaginal douching | 1.1–3.1* | |||
DES, diethylstilbestrol; PID, pelvic inflammatory disease; IUD, intrauterine device | ||||
* Range; summary odds ratio not calculated owing to significant heterogeneity between studies. |
Evaluation
Clinical features of ectopic pregnancy highly variable
No single clinical feature accurately indicates ectopic pregnancy. Less than half of women with ectopic pregnancy exhibit the classic triad of a history of amenorrhea, abdominal pain, and irregular vaginal bleeding.1 And, unfortunately, these features are seen commonly in patients with both viable (50%) and nonviable (25%) intrauterine pregnancies, as well as in threatened abortion, cervical irritation, infection, and trauma.7
Set a low threshold for suspicion. For any woman of childbearing age with abdominal pain and vaginal bleeding, consider pregnancy and take steps to rule out ectopic pregnancy. Abdominal pain and vaginal bleeding are highly sensitive for ectopic pregnancy but are not specific for the disorder (TABLE 2).8-17 Pain located in the hypogastrium or iliac fossa may be mild to severe. Vaginal bleeding, present in 50% to 80% of patients with ectopic pregnancy, can be mistaken for a normal menstrual period.2,6 Pregnancy-associated symptoms of nausea and vomiting, breast tenderness, and fatigue may be present.
Lower abdominal and adnexal tenderness can be elicited in most women with ectopic pregnancy. Cervical motion tenderness, peritoneal signs, and adnexal masses are most specific for ectopic pregnancy, but are not sensitive.8 An adnexal mass is palpable in less than 10% of cases; when it is detected, one third of patients will have a contralateral ectopic pregnancy on ultrasonography.18 Symptoms of hemodynamic compromise (orthostasis, hypotension, shock) are becoming uncommon with earlier diagnosis of ectopic pregnancy, facilitated by improved detection methods.
TABLE 2
Significance of features associated with ectopic pregnancy
FEATURES | SN (%) | SP (%) | LR+ | LR– |
---|---|---|---|---|
Clinical features8 | ||||
Any risk factors | 23 | 83 | 1.4 | 0.9 |
Estimated gestational age <70 days | 95 | 27 | 1.3 | 0.2 |
Vaginal bleeding | 69 | 26 | 0.9 | 1.2 |
Abdominal pain | 97 | 15 | 1.1 | 0.2 |
Abdominal tenderness | 85 | 50 | 1.7 | 0.3 |
Peritoneal signs | 23 | 95 | 4.6 | 0.8 |
Cervical motion tenderness | 33 | 91 | 3.7 | 0.7 |
Adnexal tenderness | 69 | 62 | 1.8 | 0.5 |
Adnexal mass | 5 | 96 | 1.3 | 1.0 |
Transvaginal ultrasound | ||||
No intrauterine gestational sac9 | 100 | 89 | 9.1 | <0.1 |
Adnexal mass10 | ||||
Separate from ovary | 93 | 99 | 93 | 0.1 |
Cardiac activity | 20 | 100 | ∞ | 0.8 |
Yolk sac or embryo | 37 | 100 | ∞ | 0.6 |
Tubal ring/yolk sac or embryo | 65 | 99 | 65 | 0.4 |
Fluid in pouch of Douglas11 | ||||
Any | 63 | 69 | 2.0 | 0.5 |
Echogenic | 56 | 96 | 14.0 | 0.5 |
Color-flow Doppler12 | 95 | 98 | 47.5 | 0.1 |
β-hCG combined with transvaginal ultrasound | ||||
Empty uterus | ||||
≥1000 mIU/mL10,13,14 | 43–96 | 86–100 | 3.0–∞ | 0.04–0.66 |
≥1500 mIU/mL13,15 | 40–99 | 84–96 | 6.3–9.9 | 0.01–0.63 |
≥2000 mIU/mL13,16 | 38–48 | 80–98 | 2.3–25.3 | 0.63–0.68 |
Adnexal mass* | ||||
≥1000 mIU/mL13 | 73 | 85 | 4.7 | 0.32 |
≥1500 mIU/mL13,15 | 46–64 | 92–96 | 5.9–16.5 | 0.38–0.58 |
≥2000 mIU/mL13 | 55 | 96 | 14.2 | 0.47 |
β-hCG rise in 48 hours (empty uterus)† | ||||
>66%17 | — | — | 1.1 | — |
<66%17 | — | — | 7.4 | — |
>50%13 | — | — | 2.8 | — |
<50%13 | — | — | 3.3 | — |
β-hCG fall in 48 hours (empty uterus)† | ||||
>50%13,17 | — | — | 0.8–1.4 | — |
<50%13,17 | — | — | 0–0.1 | — |
* Mass or fluid in cul de sac for β-hCG ≥1500 mIU/mL and ≥2000 mIU/mL. | ||||
† Strata-specific likelihood ratios reported, sensitivity and specificity not applicable. | ||||
Sn, sensitivity; Sp, specificity; LR, likelihood ratio; β-hCG, beta-human chorionic gonadotropin. |
Laboratory tests
In an early normal pregnancy, the beta-human chorionic gonadotropin (β-hCG) level doubles every 1.8 to 3 days, rising to 1000 mIU/mL IRP (International Reference Preparation, measured by radioimmunoassay) by 5 weeks, to 2500 mIU/mL by 6 weeks, and to 13,000 mIU/mL (±3000) by 7 weeks. A single quantitative β-hCG level is not always helpful, as it can range from less than 100 mIU/mL to greater than 50,000 mIU/mL with both ruptured and unruptured ectopic pregnancies.19